Department of Orthopedic, Assiut University Hospital, Assiut, Egypt.
Department of Orthopedic, Qena Faculty of Medicine and University Hospital, South Valley University, Kilo 6 Qena-Safaga Highway, Qena, 83523, Egypt.
Eur J Orthop Surg Traumatol. 2024 Jul;34(5):2549-2556. doi: 10.1007/s00590-024-03947-1. Epub 2024 May 1.
We aimed to report the early results of performing acute ankle arthrodesis using a modified retrograde femoral intramedullary locking IMN concomitant with plating at the same setting for managing diabetic patients' acute ankle fractures.
We prospectively included patients who presented acutely with ankle fractures, where hemoglobin A1C (HbA1C) on admission was > 7%, and the Adelaide Fracture in the Diabetic Ankle (AFDA) algorithm score was 5 or above. All patients were treated by acute ankle arthrodesis using a modified retrograde femoral IMN combined with lateral plating. Functional assessment was reported according to a modified American Orthopaedic Foot and Ankle Society ankle hindfoot scale (AOFAS), and complications were documented.
Six patients had an average age of 55.7 years (37-65). The average HbA1C on admission was 7.9 (7.3-9), and the average AFDA score was 7.3 (6-8). The average operative time was 79.2 min (70-90). All patients, except for one, achieved union at the arthrodesis site after an average of 10.3 weeks (8-14). After an average last follow-up of 9 months (6-12), the average modified AOFAS was 73.2 (82 to 62); four patients had an excellent score and one good. Complications developed in two, one deep infection after 2 weeks treated by metal removal and Ilizarov, and the other patient developed a stress fracture at the tibial end of the nail, which was treated by open reduction and internal fixation using a plate and screws.
Using a modified femoral IMN combined with lateral plating is a promising technique to achieve ankle arthrodesis in diabetic patients with acute ankle fractures with acceptable outcomes; however, further studies with larger numbers are needed.
IV.
我们旨在报告通过改良逆行股骨髓内锁定 IMN 联合同侧钢板固定治疗糖尿病患者急性踝关节骨折的早期结果。
我们前瞻性纳入了急性踝关节骨折患者,入院时糖化血红蛋白(HbA1C)>7%,且 Adelaide 糖尿病踝关节骨折(AFDA)评分≥5 分。所有患者均采用改良逆行股骨髓内钉联合外侧钢板固定行急性踝关节融合术治疗。采用改良美国矫形足踝协会踝关节后足评分(AOFAS)进行功能评估,并记录并发症。
6 例患者的平均年龄为 55.7 岁(37-65 岁)。入院时平均 HbA1C 为 7.9(7.3-9),平均 AFDA 评分为 7.3(6-8)。平均手术时间为 79.2 分钟(70-90 分钟)。除 1 例患者外,所有患者均在平均 10.3 周(8-14 周)后在融合部位达到愈合。平均末次随访 9 个月(6-12 个月)后,平均改良 AOFAS 评分为 73.2(82-62);4 例患者为优,1 例为良。2 例患者出现并发症,1 例在术后 2 周发生深部感染,行内固定物取出及 Ilizarov 治疗,另 1 例患者出现钉道胫骨端应力性骨折,行切开复位内固定术,使用钢板和螺钉固定。
使用改良股骨 IMN 联合外侧钢板固定是治疗糖尿病急性踝关节骨折患者的一种有前途的技术,可获得可接受的结果,但需要进一步进行更大规模的研究。
IV 级。